Latest AstraZeneca Stories
AstraZeneca Joins NTOCC Partners Council in Collaboration on Transitions of Care Solutions Washington, D.C.
CHICAGO, July 18, 2014 /PRNewswire/ -- Zacks Equity Research highlights Pep Boys (NYSE:
LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
DUBLIN, July 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the
MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved
LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON and BOSTON, June 24, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that its President,
SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published
LONDON, June 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies - KODIAC-4 and KODIAC-5
Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.